These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38755511)

  • 1. Functional impairment and quality of life in newly diagnosed adults attending a tertiary ADHD clinic in Ireland.
    Adamis D; West S; Singh J; Hanley L; Coada I; McCarthy G; Langan N; Gavin B; McNicholas F
    Ir J Med Sci; 2024 Oct; 193(5):2433-2441. PubMed ID: 38755511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Weiss Functional Impairment Rating Scale-Parent Form for assessing ADHD: evaluating diagnostic accuracy and determining optimal thresholds using ROC analysis.
    Thompson T; Lloyd A; Joseph A; Weiss M
    Qual Life Res; 2017 Jul; 26(7):1879-1885. PubMed ID: 28220338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric properties of the Weiss Functional Impairment Rating Scale parent and self-reports in a Norwegian clinical sample of adolescents treated for ADHD.
    Haugan AJ; Sund AM; Thomsen PH; Lydersen S; Nøvik TS
    Nord J Psychiatry; 2021 Jan; 75(1):63-72. PubMed ID: 32749193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional impairment outcomes in clinical trials of different ADHD medications: post hoc responder analyses and baseline subgroup analyses.
    Coghill DR; Werner-Kiechle T; Farahbakhshian S; Bliss C; Robertson B; Huss M
    Eur Child Adolesc Psychiatry; 2021 May; 30(5):809-821. PubMed ID: 32691164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Guanfacine Extended Release Impact Functional Impairment in Children with Attention-Deficit/Hyperactivity Disorder? Results from a Randomized Controlled Trial.
    Stein MA; Sikirica V; Weiss MD; Robertson B; Lyne A; Newcorn JH
    CNS Drugs; 2015 Nov; 29(11):953-62. PubMed ID: 26547425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind, multicenter, placebo-controlled, parallel-group study.
    Adler LA; Dirks B; Deas P; Raychaudhuri A; Dauphin M; Saylor K; Weisler R
    BMC Psychiatry; 2013 Oct; 13():253. PubMed ID: 24106804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric properties of the Japanese version of the Weiss Functional Impairment Rating Scale: Self-Report.
    Takeda T; Tsuji Y; Kanazawa J; Sakai T; Weiss MD
    Atten Defic Hyperact Disord; 2017 Sep; 9(3):169-177. PubMed ID: 28013402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life, functional impairment and continuous performance task event-related potentials (ERPs) in young adults with ADHD and autism: A twin study.
    Aydin Ü; Capp SJ; Tye C; Colvert E; Lau-Zhu A; Rijsdijk F; Palmer J; McLoughlin G
    JCPP Adv; 2022 Sep; 2(3):e12090. PubMed ID: 37431386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Functional Impact of Sleep Disorders in Children With ADHD.
    Craig SG; Weiss MD; Hudec KL; Gibbins C
    J Atten Disord; 2020 Feb; 24(4):499-508. PubMed ID: 28093033
    [No Abstract]   [Full Text] [Related]  

  • 10. Translating Attention-Deficit/Hyperactivity Disorder Rating Scale-5 and Weiss Functional Impairment Rating Scale-Parent Effectiveness Scores into Clinical Global Impressions Clinical Significance Levels in Four Randomized Clinical Trials of SPN-812 (Viloxazine Extended-Release) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
    Nasser A; Kosheleff AR; Hull JT; Liranso T; Qin P; Busse GD; O'Neal W; Fava M; Faraone SV; Rubin J
    J Child Adolesc Psychopharmacol; 2021 Apr; 31(3):214-226. PubMed ID: 33600233
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychometric Properties of the Weiss Functional Impairment Rating Scale: Evidence for Utility in Research, Assessment, and Treatment of ADHD in Emerging Adults.
    Canu WH; Hartung CM; Stevens AE; Lefler EK
    J Atten Disord; 2020 Oct; 24(12):1648-1660. PubMed ID: 27481918
    [No Abstract]   [Full Text] [Related]  

  • 12. The Norwegian Translation of the Adult Attention-Deficit/Hyperactivity Disorder Quality of Life Scale: Validation and Assessment of QoL in 313 Adults With ADHD.
    Gjervan B; Torgersen T; Hjemdal O
    J Atten Disord; 2019 Jul; 23(9):931-939. PubMed ID: 27033881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Attention deficit/hyperactivity disorder: burden of the disease according to subtypes in recently diagnosed children].
    Escobar R; Hervas A; Soutullo C; Mardomingo MJ; Uruñuela A; Gilaberte I
    Actas Esp Psiquiatr; 2008; 36(5):285-94. PubMed ID: 18830848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship Between Symptomatic and Functional Improvement and Remission in a Treatment Response to Stimulant Trial.
    Weiss M; Childress A; Mattingly G; Nordbrock E; Kupper RJ; Adjei AL
    J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):521-529. PubMed ID: 30036076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of DSM-5 age-of-onset criterion of attention deficit/hyperactivity disorder (ADHD) in adults: Comparison of life quality, functional impairment, and family function.
    Lin YJ; Lo KW; Yang LK; Gau SS
    Res Dev Disabil; 2015 Dec; 47():48-60. PubMed ID: 26318976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADHD in acute care psychiatric inpatients.
    Lines KL; Sadek J
    Atten Defic Hyperact Disord; 2018 Jun; 10(2):129-133. PubMed ID: 29299870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention-Deficit Hyperactivity Disorder in Adults Using Methamphetamine: Does It Affect Comorbidity, Quality of Life, and Global Functioning?
    Mihan R; Shahrivar Z; Mahmoudi-Gharaei J; Shakiba A; Hosseini M
    Iran J Psychiatry; 2018 Apr; 13(2):111-118. PubMed ID: 29997656
    [No Abstract]   [Full Text] [Related]  

  • 18. Validation of the adult attention-deficit/hyperactivity disorder quality-of-life scale in European patients: comparison with patients from the USA.
    Brod M; Adler LA; Lipsius S; Tanaka Y; Heinloth AN; Upadhyaya H
    Atten Defic Hyperact Disord; 2015 Jun; 7(2):141-50. PubMed ID: 25563210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Past Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder on Substance Use Disorder.
    Coetzee C; Schellekens AFA; Truter I; Meyer A
    Eur Addict Res; 2023; 29(1):9-18. PubMed ID: 36349763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.